A TV news interview with 5k founder Greg Schnoor about the upcoming event and his support for ABC2.
NCI Director Harold Varmus, ABC2 CEO Max Wallace and prominent cancer researchers exchanged ideas with leading pediatric cancer advocates.
The panel focused on new funding models for disease research foundations, including for-profit direct investment in early stage biotech/medtech companies.
The 17 member advisory panel will help PBTF evaluate research funding priorities and guide investments.
Drs. Linda Liau and Albert Lai discussed the future of brain cancer research with ABC2 CEO Max Wallace and brain tumor community guests.
Our beloved ABC2 teammate Mark Green was recently interviewed by our good friend Alex Case about living with brain cancer.
Drs. Maria Castro and Pedro Lowenstein, both of the U-M Department of Neurosurgery, co-led the research.
Guest blogger Lisa Peabody shares her personal story and her experience as an advocate at the recent Alliance for Childhood Cancer Action Day.
ABC2 helped fund the early-stage research by Dr. Andrew Parsa that is now being developed by Agenus.
Join us for the screening and meet Maria Parker, the inspiring cyclist profiled in the film. Proceeds benefit 3000 Miles To A Cure in partnership with ABC2.
Progress continues on the UF pediatric immunotherapy trial funded by ABC2, FBTA and Paul Hale of the Bret Hale Memorial Fund.
The 2014 Marine Corps Marathon is just around the corner. Mary Pang writes about her 2013 MCM experience and why she supports ABC2.
ABC2 funded the research of Hai Yan, M.D., Ph.D., at Duke University School of Medicine.
This ABC2-funded research by Dr. Greg Riggins at Johns Hopkins University is featured in The Baltimore Sun.
We've funded early research at Duke that's now being developed by Celldex - a leading company featured in the Seeking Alpha article.
BethAnn Telford, a brain cancer survivor and Ironman athlete, is the inspiration behind the summer hotel promotion.
In May, our San Diego gathering featured a discussion with leading academic and industry brain cancer researchers.
A message from Max Wallace, CEO of Accelerate Brain Cancer Cure.
Over $22 Million Raised Since 1998; American Idol® David Cook Returns as Honorary Chair
More than 1400 participants, 73 teams and dozens of sponsors raised $209,000 for brain cancer research in the state of Florida.
ABC2's Max Wallace leads the NCI's Director's Consumer Liaison Group that addresses research issues critical to improving outcomes for patients with all types of cancers.
The coalition includes Accelerate Brain Cancer Cure, the Musella Foundation for Brain Tumor Research and Information, the National Brain Tumor Society and the Society for Neuro-Oncology.
An in-depth update from Medscape on the debate surrounding the use of Avastin in treating GBM. ABC2's petitioning of the FDA is noted.
An interview with biogeneticist Eric S. Lander in the January/February issue of The Atlantic.
Dr. Shawn Carbonell is OncoSynergy's CEO and his wife, Dr. Anne-Marie Carbonell, is the VP of Clinical Development. OncoSynergy is the Social Media Sponsor of the 2014 Race for Hope DC.